Kaplan Fox Reminds Investors of an Ongoing Investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) for Possible Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC).

On July 8, 2026, news emerged that a former Alignment Healthcare executive had filed a whistleblower complaint alleging the Company engaged in “accounting irregularities” that “artificially inflated” Alignment Healthcare’s previously reported and projected financial results, including “Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“Adjusted EBITDA”), a key non-GAAP financial metric central to the Company’s reported financial performance and executive compensation structure.” According to the lawsuit “millions of dollars in operating expenses had been systematically misclassified as capital expenditures.”

Following this news, on July 8, 2026, the price of Alignment Healthcare stock fell $4.02 per share, or 16.7%, to close at $20.03 per share.